tiprankstipranks
Reneo Pharmaceuticals (RPHM)
NASDAQ:RPHM
US Market

Reneo Pharmaceuticals (RPHM) Cash flow

222 Followers

Reneo Pharmaceuticals Cash Flow

RPHM's free cash flow for Q3 2023 was $―. For the 2023 fiscal year, RPHM's free cash flow was decreased by $-9.53M and operating cash flow was $-18.77M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -59.54M$ -47.36M$ -37.98M$ -18.54M$ -12.51M
Investing Cash Flow
$ -56.17M$ -57.84M$ -23.38M$ 7.38M$ -7.24M
Financing Cash Flow
$ 65.32M$ 471.00K$ 132.41M$ 47.27M$ 24.99M
Cash Flow From Discontinued Operation
-----
Other Cash Adjustment Inside Changein Cash
-----
End Cash Position
$ 71.14M$ 19.93M$ 171.90M$ 53.61M$ 17.50M
Income Tax Paid Supplemental Data
-----
Interest Paid Supplemental Data
-----
Issuance Of Capital Stock
$ 4.86M$ 193.00K$ 84.61M$ 47.19M$ 24.96M
Issuance Of Debt
-----
Repayment Of Debt
-----
Free Cash Flow
$ -41.20M$ -47.71M$ -38.18M$ -18.56M$ -12.52M
Domestic Sales
-----
Foreign Sales
-----
Currency in USD

Reneo Pharmaceuticals Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis